CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.13 ($3,966)
- 4/A Open-market buy CEO,Pres,Exec Vice Chairman bought 40,000 shares at an average $0.16 ($6,310)
- 4/A Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.16 ($4,890)
- 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 40,000 shares at an average $0.16 ($6,310)
- 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.16 ($4,890)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,488)
Page 19 of 31 · 616 filings